Janus Henderson Group’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $266M | Buy |
5,236,277
+470,168
| +10% | +$23.9M | 0.13% | 162 |
|
|
2025
Q1 | $219M | Buy |
4,766,109
+184,467
| +4% | +$8.49M | 0.12% | 178 |
|
|
2024
Q4 | $189M | Buy |
4,581,642
+101,358
| +2% | +$4.19M | 0.1% | 200 |
|
|
2024
Q3 | $175M | Sell |
4,480,284
-508,463
| -10% | -$19.8M | 0.09% | 202 |
|
|
2024
Q2 | $171M | Buy |
4,988,747
+2,221,537
| +80% | +$76M | 0.09% | 192 |
|
|
2024
Q1 | $69.5M | Buy |
2,767,210
+704,659
| +34% | +$17.7M | 0.04% | 326 |
|
|
2023
Q4 | $60.9M | Buy |
2,062,551
+138,791
| +7% | +$4.1M | 0.04% | 337 |
|
|
2023
Q3 | $60.8M | Buy |
1,923,760
+1,658,148
| +624% | +$52.4M | 0.04% | 331 |
|
|
2023
Q2 | $6.86M | Buy |
265,612
+224,328
| +543% | +$5.8M | ﹤0.01% | 769 |
|
|
2023
Q1 | $991K | Buy |
+41,284
| New | +$991K | ﹤0.01% | 1636 |
|